Why Legend Biotech Shares Plummeted 17.6% Wednesday

Why Legend Biotech Shares Plummeted 17.6% Wednesday

Source: 
Motley Fool
snippet: 
  • The company announced plans for a $300 million stock sale.
  • Legend is looking at several CAR T-cell therapies to fight cancer.